News · Nutrition & Diet
B vitamins tracked slightly less breast cancer, but not in women drinking more than a glass a day
Folate and its relatives have been circling breast cancer research for decades without resolving. A nested study found small protective associations, and found they disappeared above a specific drinking threshold.
- Higher intakes of two B vitamins tracked modestly lower breast cancer risk.
- The effects are small, in the range of 6 to 7% per step up in intake.
- The association vanished in women drinking more than about a glass of wine a day.
- Genetic risk did not change whether the vitamins mattered.
- Diet was measured by questionnaire, which is the weak link.
Folate and breast cancer have been arguing with each other in the literature since the 1990s. Some studies find protection, some find harm, and the usual explanation offered is that the nutrient does different things at different stages of a cancer’s life.
Underneath the argument is a real mechanism. Folate, riboflavin, B6 and B12 run a linked set of reactions that build DNA and decide which genes are read, and both of those processes sit close to how tumors start.
Writing in The American Journal of Clinical Nutrition, researchers looked at the whole pathway at once, testing nutrient intakes, gene expression in fat tissue and inherited risk together against breast cancer. Previously these three had been examined separately, which is part of why the literature never settled.
The associations, and their size
Two vitamins came out ahead individually. Higher intakes of vitamin B2 and vitamin B12 were each associated with modestly lower risk, in the range of 6 to 7% per standard deviation of intake.
A combined score across the B vitamins showed a smaller association again, around 3%.
These are not large numbers, and their ranges sit close to no effect. Reported alone they would be an unremarkable addition to an ambiguous literature.
The threshold that makes it interesting
What lifts the paper is the alcohol result. The inverse association between B-vitamin score and breast cancer risk varied by alcohol consumption, and it disappeared entirely above a specific intake.
That intake is 16 grams a day. Roughly a large glass of wine, a little over one standard drink. Not heavy drinking, not a level most people would describe as a problem.
Above it, whatever the B vitamins were doing stopped being detectable.
Why that is biologically coherent
Alcohol and folate have a known quarrel. Alcohol impairs folate absorption in the gut, accelerates its excretion, and interferes with the enzymes that move it through one-carbon metabolism.
So a finding that alcohol abolishes a B-vitamin association is not a statistical curiosity looking for an explanation. It is what the biochemistry predicts, which is a meaningful point in favor of the association being real rather than noise.
It also runs the other way as a warning. Alcohol is itself an established breast cancer risk factor, and this suggests one route by which it might work: not only its own toxicity, but by disabling a protective pathway.
The genetics that did not matter
The study also carried polygenic risk scores, which summarize inherited breast cancer risk across many common variants.
No interaction was found. The vitamin associations looked much the same in women at high and low inherited risk, which argues against the appealing idea that nutrition matters most for the genetically vulnerable.
Separately, lower expression of one-carbon metabolism genes in fat tissue was associated with higher risk among premenopausal women but not postmenopausal ones, a difference the study reports without resolving.
The weak link
Everything here rests on dietary questionnaires, and the B vitamins are among the harder nutrients to capture that way. The group runs B1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), B6, B7 (biotin), B12 and folic acid, eight compounds tracked as one.
They occur across a wide range of foods, they are added to fortified products in amounts people do not track, and intake varies day to day. A questionnaire estimate of B2 intake is a noisy proxy for what actually reached the tissue.
Nested case-control designs also compare cases against selected controls from within the same cohort, which is efficient and introduces its own selection questions.
What it is worth
Not a recommendation. Six percent per standard deviation of intake is not a number anyone should reorganize their diet around, and the study measured food rather than supplements, which matters because high-dose folate supplementation has its own contested and occasionally alarming literature in cancer.
Where it lands is on the alcohol question. The finding that a modest, ordinary level of drinking wipes out a nutritional association is more useful than the association itself, and it is a specific, testable claim about how alcohol harms.
People also ask
What did the study find?
Per one standard deviation higher intake, inverse associations with breast cancer risk were seen for vitamin B2 (OR 0.93; 95% CI 0.87, 0.99), vitamin B12 (OR 0.94; 0.89, 0.99) and a combined B-vitamin score (OR 0.97; 0.95, 0.99). The B-vitamin association varied by alcohol consumption and was not observed among women consuming more than 16 g/day.
What is one-carbon metabolism?
A set of linked chemical reactions that use folate, B2, B6 and B12 to build and repair DNA and to control which genes are switched on. Both functions matter to how cancers start, which is why these nutrients keep appearing in cancer research.
How much alcohol is 16 grams a day?
Roughly a large glass of wine, or a little over a standard drink in most countries. It is not heavy drinking, which is what makes the threshold notable.
Why would alcohol cancel the effect?
Alcohol interferes with folate absorption and metabolism, which is a long-established interaction. If the B vitamins act through one-carbon metabolism, then something disrupting that pathway would be expected to blunt them.
Are these effects large?
No. Six or seven percent per standard deviation of intake is small, and the intervals run close to no effect. This is a contribution to a long-running question rather than a reason to change anything.
Did genetic risk matter?
No interaction was found between the nutritional scores and polygenic risk scores, meaning the vitamin associations looked similar in women at higher and lower inherited risk.
Should women take B vitamin supplements?
Nothing here supports that. The study measured dietary intake, not supplements, and high-dose folate supplementation has its own contested literature in cancer. This is general information rather than medical advice.